Androgens
New Treatment Combination for Metastatic Prostate Cancer Available on the NHS
People living with metastatic prostate cancer in England will gain access to a new treatment combination from Friday, 24 October, following a recommendation by NICE. The treatment, darolutamide, made by Bayer, has been recommended in final draft guidance to treat adults with metastatic hormone-sensitive prostate cancer in combination with androgen